Kristina Patek, a board member of the life science company Addlife, made her first purchase of company shares on November 24. Patek acquired 1,000 class B shares at a price of SEK 182.10 per share, corresponding to a total transaction value of SEK 182,100.
The transaction was executed on Nasdaq Stockholm, as reported in the Swedish Financial Supervisory Authority's insider register.
According to the shareholder service Holdings, Patek previously did not own any shares in Addlife. She has served as a board member since the annual general meeting on May 8.
